FDA Approves Expanded Liquid Biopsy Panel - Top-Institutions - MDSpire

FDA Approves Expanded Liquid Biopsy Panel

  • By

  • Kathryn Wighton

  • May 20, 2026

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Liquid Biopsy

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology
    • Liquid Biopsy

  • #3

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Translational Research

  • #4

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology
    • Clinical Research

Original Source(s)

FDA Approves Expanded Liquid Biopsy Panel

  • by Kathryn Wighton

  • May 20, 2026

Related Content

Digital Pathology: the Great Translation Debate

Conference discussions highlighted collaboration, resilience, and the realities of AI adoption in pathology labs

DNA Quality Outweighs Bone Source

Background DNA burden was more strongly associated with sequencing profile completeness than bone source in unidentified human remains.

Could Digital Twins Forecast Forensic Risk?

Researchers outline a proposed three-level framework spanning patient monitoring, ward operations, and forensic system planning.